Restoration of arterial blood flow to severely and acutely ischemic extremities results in tissue necrosis and systemic-metabolic complications associated with multiorgan failure and death. Surgical revascularization alone (SRA) was compared with revascularization and controlled reperfusion using standard cardiopulmonary bypass (R-CPB) in 41 patients with acute lower limb ischemia and ischemia-induced neurological dysfunction. The mean ischemia time was 17 ± 10 hours. Eighteen patients (44%) had unilateral femoral artery occlusion, 23 (56%) had distal aortic occlusion. Eleven patients (27%) presented ischemia-induced paraplegia. SRA was performed in 23 patients (56%), and R-CPB in 18 (44%). End-points were hospital mortality, lower limb amputation, the number of surgical fasciotomies, and the incidence of permanent neurological morbidity. Hospital mortality was 19.5%; it was 33% after SRA, and 5.5% with R-CPB (p = 0.007). R-CBP was superior to SRA in terms of amputation rate (0% vs. 21.7%, p = 0.056), number of fasciotomies performed (7% vs. 64%, p = 0.002), and neurological recovery (86% vs. 19%, p = 0.000). After acute lower limb ischemia controlled reperfusion using standard cardiopulmonary bypass techniques preserves skeletal muscle and nerve function and prevents local as well as systemic complications of postischemic restoration of bloodflow.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.